WASHINGTON – The National Association of Chain Drug Stores today issued a statement regarding the House Energy and Commerce Committee’s anticipated markup of The Seniors’ Access to Critical Medications Act (H.R. 2484), clarifying concerns about the bill’s potential impact on patients and pharmacies.
“In its current form, this bill would undermine the pro-patient benefits of the pharmacist’s role in medication dispensing. It also would undermine safeguards in current law that prohibit physician self-referral within the Medicare program. We want members of Congress to know clearly that, contrary to this bill’s positioning, the legislation currently is not limited to cancer treatments. Rather, it applies broadly to all Part D drugs.
“NACDS has provided recommendations that would prevent harm to patients, to the Medicare program, to pharmacies, and to all who rely on them. NACDS looks forward to continuing to work with leaders in Congress to amend the legislation as needed. At this time, and until adequate changes are made, NACDS has no choice but to oppose the legislation.
“NACDS appreciates the leadership of Committee members to advance issues of vital importance to Americans and to their pharmacies. NACDS continues to advocate for necessary legislative priorities, and to prevent the unintended consequences of other bills as they arise.”
The NACDS reaffirmed its commitment to collaborating with lawmakers to ensure that pharmacy services continue to play a vital, protected role in the nation’s healthcare system.
